Top Biotechnology companies in Europe by Cash and Short-Term Investments

This ranking features the top 259 Biotechnology companies in Europe ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 126.84 B, for July 06, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Europe has the highest Cash and Short-Term Investments ?

The Biotechnology company in Europe with the highest Cash and Short-Term Investments is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 19.07 B.

Which Biotechnology company in Europe has the lowest Cash and Short-Term Investments ?

The Biotechnology company in Europe with the lowest Cash and Short-Term Investments is aXichem AB (Stockholm Stock Exchange: AXIC-A.ST) at None.

What are the top 10 Biotechnology companies in Europe by Cash and Short-Term Investments ?

The top 10 Biotechnology companies in Europe by Cash and Short-Term Investments are Roche Holding AG, BioNTech SE, Novartis AG, Bayer AG, Sanofi, AstraZeneca PLC, Roivant Sciences Ltd., GSK plc, Novo Nordisk A/S and Siemens Healthineers AG.

What are the bottom 10 Biotechnology companies in Europe by Cash and Short-Term Investments ?

The bottom 10 Biotechnology companies in Europe by Cash and Short-Term Investments are aXichem AB, Bioceltix S.A., Aptahem AB (publ), AlzeCure Pharma AB (publ), AddLife AB (publ), Akari Therapeutics, Plc, AcouSort AB (publ), Alzinova AB (publ), 2cureX AB (publ) and Bicycle Therapeutics plc.